Risk factors and outcome associated with the acquisition of linezolid-resistant Enterococcus faecalis

Arias, 2012, The rise of the Enterococcus: beyond vancomycin resistance, Nat Rev Microbiol, 10, 266, 10.1038/nrmicro2761 Hollenbeck, 2012, Intrinsic and acquired resistance mechanisms in enterococcus, Virulence, 3, 421, 10.4161/viru.21282 Pfaller, 2019, Temporal and geographic variation in antimicrobial susceptibility and resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997–2016, Open Forum Infect Dis, 6, S54, 10.1093/ofid/ofy344 Murray, 2000, Vancomycin-resistant enterococcal infections, N Engl J Med, 342, 710, 10.1056/NEJM200003093421007 Chacko, 2018, Enterococcus faeciumGenetic basis of emerging vancomycin, linezolid, and daptomycin heteroresistance in a case of persistent bacteremia, Antimicrob Agents Chemother, 62, 10.1128/AAC.02007-17 Deshpande, 2018, Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program, J Antimicrob Chemother, 73, 2314, 10.1093/jac/dky188 Auckland, 2002, Linezolid-resistant enterococci: report of the first isolates in the United Kingdom, J Antimicrob Chemother, 50, 743, 10.1093/jac/dkf246 Ruggero, 2003, Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs, Diagn Microbiol Infect Dis, 47, 511, 10.1016/S0732-8893(03)00153-6 Burleson, 2004, Enterococcus faecalis resistant to linezolid: case series and review of the literature, Pharmacotherapy, 24, 1225, 10.1592/phco.24.13.1225.38086 Sanchez-Gomez, 2006, Linezolid-resistant Enterococcus faecalis: first report in Spain, J Chemother, 18, 440, 10.1179/joc.2006.18.4.440 Lopez-Salas, 2013, Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance, Arch Med Res, 44, 422, 10.1016/j.arcmed.2013.07.003 de Almeida, 2014, Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital, Antimicrob Agents Chemother, 58, 2993, 10.1128/AAC.02399-14 Diaz, 2012, Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis, Antimicrob Agents Chemother, 56, 3917, 10.1128/AAC.00419-12 Baccani, 2017, Linezolid-resistant Enterococcus faecalis infection following prolonged low-dosage linezolid treatment for multidrug-resistant tuberculosis, Clin Infect Dis, 65, 2159, 10.1093/cid/cix729 Chen, 2018, Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis, Infect Drug Resist, 11, 2397, 10.2147/IDR.S181339 Gomez-Gil, 2009, Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital, Diagn Microbiol Infect Dis, 65, 175, 10.1016/j.diagmicrobio.2009.06.010 Wang, 2014, Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China, Infect Genet Evol, 26, 14, 10.1016/j.meegid.2014.05.001 Ntokou, 2012, Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium, J Antimicrob Chemother, 67, 1819, 10.1093/jac/dks146 Bai, 2019, Enterococcus faecalisLinezolid consumption facilitates the development of linezolid resistance in in a tertiary-care hospital: a 5-year surveillance study, Microb Drug Resist, 25, 791, 10.1089/mdr.2018.0005 Harris, 2001, Methodological principles of case–control studies that analyzed risk factors for antibiotic resistance: a systematic review, Clin Infect Dis, 32, 1055, 10.1086/319600 Harris, 2002, Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli, Clin Infect Dis, 34, 1558, 10.1086/340533 Schaberg, 1991, Major trends in the microbial etiology of nosocomial infection, Am J Med, 91, 72S, 10.1016/0002-9343(91)90346-Y Emori, 1993, An overview of nosocomial infections, including the role of the microbiology laboratory, Clin Microbiol Rev, 6, 428, 10.1128/CMR.6.4.428 Diekema, 2004, Antimicrobial resistance trends and outbreak frequency in United States hospitals, Clin Infect Dis, 38, 78, 10.1086/380457 Schwarz, 2000, Identification of a plasmid-borne chloramphenicol–florfenicol resistance gene in Staphylococcus sciuri, Antimicrob Agents Chemother, 44, 2530, 10.1128/AAC.44.9.2530-2533.2000 Gonzales, 2001, Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid, Lancet, 357, 1179, 10.1016/S0140-6736(00)04376-2 Herrero, 2002, Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium, N Engl J Med, 346, 867, 10.1056/NEJM200203143461121 Dobbs, 2006, Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center, J Clin Microbiol, 44, 3368, 10.1128/JCM.00850-06 Cafini, 2016, Horizontal gene transmission of the cfr gene to MRSA and Enterococcus: role of Staphylococcus epidermidis as a reservoir and alternative pathway for the spread of linezolid resistance, J Antimicrob Chemother, 71, 587, 10.1093/jac/dkv391 Pai, 2002, Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium, Clin Infect Dis, 35, 1269, 10.1086/344177 Smith, 2018, Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium, Diagn Microbiol Infect Dis, 91, 161, 10.1016/j.diagmicrobio.2018.01.027 Greene, 2018, Risk factors and outcomes associated with acquisition of daptomycin and linezolid-nonsusceptible vancomycin-resistant Enterococcus, Open Forum Infect Dis, 5, 10.1093/ofid/ofy185 Scheetz, 2008, Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption, Antimicrob Agents Chemother, 52, 2256, 10.1128/AAC.00070-08 Souli, 2009, Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis, Int J Antimicrob Agents, 33, 137, 10.1016/j.ijantimicag.2008.08.017 Cho, 2018, Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: a single-centre study in South Korea, J Glob Antimicrob Resist, 12, 44, 10.1016/j.jgar.2017.09.009 Mendes, 2010, First report of staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization, J Clin Microbiol, 48, 3041, 10.1128/JCM.00880-10 Zasowski, 2016, Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections, Clin Infect Dis, 62, 1242, 10.1093/cid/ciw110 Bi, 2018, The emerging problem of linezolid-resistant enterococci, J Glob Antimicrob Resist, 13, 11, 10.1016/j.jgar.2017.10.018 Garcia-Solache, 2019, The Enterococcus: a model of adaptability to its environment, Clin Microbiol Rev, 32, 10.1128/CMR.00058-18 Vester, 2018, cfrThe and cfr-like multiple resistance genes, Res Microbiol, 169, 61, 10.1016/j.resmic.2017.12.003 Garza-Gonzalez, 2019, A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period, PLoS One, 14, 10.1371/journal.pone.0209865 Garcia-Martinez, 2016, Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study, J Antimicrob Chemother, 71, 2606, 10.1093/jac/dkw179